Have a feature idea you'd love to see implemented?
Let us know!
IRWD Ironwood Pharmaceuticals Inc
Price (delayed)
$4.45
Market cap
$712.13M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.02
Enterprise value
$1.24B
Ironwood Pharmaceuticals is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. The company discovered, developed and are commercializing linaclotide, the
Highlights
IRWD's debt is down by 17% year-on-year and by 4% since the previous quarter
The company's equity rose by 3.7% YoY and by 3.2% QoQ
The EPS has dropped by 133% since the previous quarter but it has surged by 100% year-on-year
The net income has plunged by 127% from the previous quarter but it has soared by 100% YoY
Ironwood Pharmaceuticals's gross profit has decreased by 12% YoY and by 6% QoQ
IRWD's revenue is down by 12% YoY and by 6% QoQ
Key stats
What are the main financial stats of IRWD
Market
Valuations
Earnings
Shares outstanding
160.03M
Market cap
$712.13M
Enterprise value
$1.24B
Price to book (P/B)
N/A
Price to sales (P/S)
1.88
EV/EBIT
11.82
EV/EBITDA
11.6
EV/Sales
3.27
Revenue
$378.42M
Gross profit
$378.42M
Net income
-$2.46M
EBIT
$104.76M
EBITDA
$106.8M
Free cash flow
$123.82M
Per share
Balance sheet
Liquidity
EPS
-$0.02
EPS diluted
-$0.02
Free cash flow per share
$0.78
Book value per share
-$1.95
Revenue per share
$2.37
TBVPS
$2.42
Total assets
$389.52M
Total liabilities
$700.85M
Debt
$614.87M
Equity
-$311.33M
Working capital
$129.22M
Debt to equity
-1.97
Current ratio
3.62
Quick ratio
3.33
Net debt/EBITDA
4.93
Margins
Efficiency
Dividend
EBITDA margin
28.2%
Gross margin
100%
Net margin
-0.7%
Operating margin
26.2%
Return on assets
-0.6%
Return on equity
N/A
Return on invested capital
12.7%
Return on capital employed
30.8%
Return on sales
27.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRWD stock price
How has the Ironwood Pharmaceuticals stock price performed over time
Intraday
14.69%
1 week
26.06%
1 month
26.42%
1 year
-59.55%
YTD
-61.1%
QTD
8.01%
Financial performance
How have Ironwood Pharmaceuticals's revenue and profit performed over time
Revenue
$378.42M
Gross profit
$378.42M
Operating income
$99.22M
Net income
-$2.46M
Gross margin
100%
Net margin
-0.7%
IRWD's net margin has dropped by 130% since the previous quarter but it has surged by 100% year-on-year
The net income has plunged by 127% from the previous quarter but it has soared by 100% YoY
IRWD's operating margin has surged by 112% year-on-year but it is down by 8% since the previous quarter
The operating income has soared by 111% YoY but it has decreased by 13% from the previous quarter
Growth
What is Ironwood Pharmaceuticals's growth rate over time
Valuation
What is Ironwood Pharmaceuticals stock price valuation
P/E
N/A
P/B
N/A
P/S
1.88
EV/EBIT
11.82
EV/EBITDA
11.6
EV/Sales
3.27
The EPS has dropped by 133% since the previous quarter but it has surged by 100% year-on-year
The company's equity rose by 3.7% YoY and by 3.2% QoQ
IRWD's P/S is 53% below its 5-year quarterly average of 4.0 and 35% below its last 4 quarters average of 2.9
IRWD's revenue is down by 12% YoY and by 6% QoQ
Efficiency
How efficient is Ironwood Pharmaceuticals business performance
Ironwood Pharmaceuticals's return on assets has shrunk by 130% QoQ but it has surged by 99% YoY
The return on sales has surged by 114% year-on-year but it has declined by 8% since the previous quarter
Ironwood Pharmaceuticals's ROIC has soared by 113% YoY but it has decreased by 13% from the previous quarter
Dividends
What is IRWD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRWD.
Financial health
How did Ironwood Pharmaceuticals financials performed over time
The total assets is 44% less than the total liabilities
The total assets has contracted by 26% YoY
IRWD's total liabilities is down by 18% year-on-year and by 2.3% since the previous quarter
IRWD's debt is down by 17% year-on-year and by 4% since the previous quarter
The company's debt to equity rose by 14% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.